Zinc is one of the most studied trace elements, commonly used as supplement in diabetes
treatment. By its involvement in the synthesis, secretion of insulin, promotion of insulin …

Zinc oxide nanoparticles (ZnONPs) have shown antidiabetic activity in multiple studies and
can be produced by different plant-mediated (“green”) methods. This study aimed to …

The antidiabetic, hypoglycemic and oral glucose tolerance test (OGTT) activities of zinc
oxide nanoparticles (ZnONPs) were assessed in mice. ZnONPs were prepared by reacting …

Different studies in experimental diabetes models suggest that zinc oxide nanoparticles
(ZnONPs) are useful as antidiabetic agents. However, this evidence was performed and …

Aim: to produce unique products with novel properties, to manipulate materials at the nano-
scale level. Nanoparticles demonstrate novel or improved characteristics which are …

In this current investigation, zinc oxide nanoparticles (ZnONPs) were synthesized from
Croton joufra leaves extract containing zinc nitrate as a precursor. Reducing zinc nitrate to …

Diabetes mellitus (DM) is a multifaceted and costly disease, which requires serious
attention. Finding a cheaper anti-diabetic alternative that can act on multiple disease-related …

Aim: The correlation of diabetes and an imbalance in zinc homeostasis makes zinc-based
therapy an attractive proposition. In this study, zinc oxide nanoparticles were evaluated for …

Sulphonylureas are extensively used in the treatment of type II diabetes; however, these
drugs have complications of hypoglycaemia and weight gain. The current study aims at …

This study attempted to scrutinize the potential efficacy of zinc oxide nanoparticles (ZnONPs)
and the standard oral hypoglycemic drug glibenclamide in streptozotocin (STZ) …